| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Gossamer Bio Inc (NASDAQ: GOSS)
GOSS Technical Analysis
5
| As on 9th Jun 2023 GOSS STOCK Price closed @ 1.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.20 & Strong Sell for SHORT-TERM with Stoploss of 10.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GOSSSTOCK Price
| Open | 1.22 | Change | Price | % |
| High | 1.26 | 1 Day | -0.09 | -7.14 |
| Low | 1.13 | 1 Week | -0.13 | -10.00 |
| Close | 1.17 | 1 Month | 0.05 | 4.46 |
| Volume | 1715800 | 1 Year | -9.57 | -89.11 |
| 52 Week High 14.88 | 52 Week Low 0.96 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GOSS Daily Charts |
GOSS Intraday Charts |
Whats New @ Bazaartrend |
GOSS Free Analysis |
|
|
GOSS Important Levels Intraday
| RESISTANCE | 1.42 |
| RESISTANCE | 1.34 |
| RESISTANCE | 1.29 |
| RESISTANCE | 1.24 |
| SUPPORT | 1.10 |
| SUPPORT | 1.05 |
| SUPPORT | 1.00 |
| SUPPORT | 0.92 |
GOSS Forecast May 2024
| 4th UP Forecast | 9.92 |
| 3rd UP Forecast | 7.11 |
| 2nd UP Forecast | 5.38 |
| 1st UP Forecast | 3.64 |
| 1st DOWN Forecast | -1.3 |
| 2nd DOWN Forecast | -3.04 |
| 3rd DOWN Forecast | -4.77 |
| 4th DOWN Forecast | -7.58 |
GOSS Weekly Forecast
| 4th UP Forecast | 3.60 |
| 3rd UP Forecast | 2.82 |
| 2nd UP Forecast | 2.34 |
| 1st UP Forecast | 1.86 |
| 1st DOWN Forecast | 0.48 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | -0.48 |
| 4th DOWN Forecast | -1.26 |
GOSS Forecast2024
| 4th UP Forecast | 28.71 |
| 3rd UP Forecast | 19.88 |
| 2nd UP Forecast | 14.42 |
| 1st UP Forecast | 8.96 |
| 1st DOWN Forecast | -6.62 |
| 2nd DOWN Forecast | -12.08 |
| 3rd DOWN Forecast | -17.54 |
| 4th DOWN Forecast | -26.37 |
Gossamer Bio Inc ( NASDAQ USA Symbol : GOSS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GOSS Business Profile
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2, which is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma; in Phase II clinical trial to treat patients with chronic rhinosinusitis with and without nasal polyps; and in Phase 2 clinical trial in patients with chronic spontaneous urticarial. The company is also developing GB002, an orally inhaled, small molecule, platelet-derived growth factor receptor kinase inhibitor in Phase Ib clinical trial for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule in Phase Ib clinical trial for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; and GB1275, an oral, small molecule, CD11b modulator in Phase 1/2 clinical trial for the treatment of selected solid tumor types. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Address: 3013 Science Park Road, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service